Study of the analgesic effects of repeated doses of F13640 in spinal cord injury patients with moderate to severe central neuropathic pain. A multinational, multicenter, randomized, double blind, parallel groups, placebo-controlled study.
Phase of Trial: Phase II
Latest Information Update: 29 Dec 2012
At a glance
- Drugs Befiradol (Primary)
- Indications Neuropathic pain
- Focus Pharmacogenomic; Therapeutic Use
- 18 Aug 2011 New trial record